Immunological evaluation of the new stable ultrasound contrast agent LK565: a phase one clinical trial

BACKGROUND: Ultrasound contrast agents (UCAs) allow the enhancement of vascular definition, thereby providing more diagnostic information. LK565 is a new second-generation UCA based on synthetic polymers of aspartic acid which is eliminated from the blood stream via phagocytosis. LK565 forms very st...

詳細記述

書誌詳細

出版年:	Cardiovasc Ultrasound
主要な著者:	Funke, B, Maerz, HK, Okorokow, S, Polata, S, Lehmann, I, Sack, U, Wild, P, Geisler, T, Zotz, RJ
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2004
主題:	Research
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC520823/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15357870/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1476-7120-2-16
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!